Finally, in a cohort of stage IV melanoma patients, we found increased circulating levels of neutrophil-related mediators, such as MMP-9, MPO, GM-CSF and CXCL8/IL-8, as well as increased levels of NET biomarkers, compared to healthy controls. The gene discussed is CXCL8; the disease is melanoma.